Demonstration of increased collagen synthesis in irradiated human skin in vivo. by Autio, P. et al.
British Joumal ofCancer (1998) 77(12), 2331-2335
X 1998 Cancer Research Campaign
Demonstration of increased collagen synthesis in
irradiated human skin in vivo
P Autiol, T Saarto2, M Tenhunen2, I Elomaa2, J Risteli3 and T Lahtinen4
Departments of 'Dermatology and 20ncology, University of Helsinki, Helsinki; 3Departments of Clinical Chemistry and Medical Biochemistry, University of Oulu,
Oulu and Department of Oncology, Kuopio University Hospital, Kuopio; 4Research Institute for Radiotherapy Physics, University of Kuopio, Kuopio, Finland
Summary Fibrosis is a common side-effect of radiation therapy. As a complex network of cytokines and other mediators plays a central role
in the process leading to fibrosis, we used an in vivo method to measure skin collagen synthesis, taking into account the physiological
conditions. We determined suction blister (i.e. interstitial) fluid concentrations of types and IlIl procollagen propeptides, reflecting types I and
Ill collagen synthesis, in irradiated and unirradiated skin of breast cancer patients 1-5 years after surgery and radiation therapy, hence using
the patients as their own controls. The mean concentrations of the measured collagen markers were approximately two times higher in the
irradiated skin than in the unirradiated contralateral breast skin. The difference slowly diminishes with time. These results indicate that
abundant collagen synthesis in the irradiated skin continues several years after discontinuation of the radiation therapy, leading to fibrosis.
The method outlined here offers a new in vivo perspective to study events leading to radiation fibrosis.
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Fibrosis is a common side-effect of radiation therapy, resulting
from the overproduction or decreased degradation of collagen.
Collagen synthesis takes place in fibroblasts. However, very little
is known about the details ofthe process leading to fibrosis. It has
been suggested that interleukin 2 secretion in fibroblasts and the
subsequent up-regulation of adhesion molecules ICAM-1 and
CD44 may be fundamental events in this process (Alileche et al,
1994). Furthermore, increased synthesis and secretion of
macrophage-derived growth factors for fibroblasts, such as
platelet-derived growth factor (PDGF) and insulin-like growth
factor 1 (IGF-1), may play a central role in lung fibrosis resulting
from thoracic radiation therapy (Thornton et al, 1996). Trans-
forming growth factor beta (TGF-,B) is a cytokine and a well-
known collagen synthesis inducer that also evidently contributes
to the fibrosis formation during radiation therapy (Cromarck et al,
1993; Rodemann and Bamberg, 1995; Thornton et al, 1996). In
mucocutaneous tissues, increased vascular permeability resulting
in fibrin deposition and collagen formation has been indicated to
lead to fibrosis after radiation therapy (Cooper et al, 1995).
Irradiation induces the terminal differentiation of cultured fibro-
blasts, which consequently contributes to the late effects of radia-
tion therapy, including fibrosis formation (Rodemann et al, 1991).
Individual variation exists in normal tissue response to radiation
therapy, leading in certain cases to fibrosis (Bentzen and
Overgaard, 1994). There is a wide individual variation in sensitivity
of skin fibroblasts to radiation therapy, and it has been suggested
that radiosensitivity may predict the late effects (Geara et al, 1993)
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or the acute effects (Burnet et al, 1992) ofthe therapy. Patients with
a genetic or acquired disorder, such as ataxia teleangiectasia
(Taylor et al, 1975) or systemic sclerosis (Varga et al, 1991) exhibit
abnormal sensitivity to ionizing radiation. However, the individual
variation of tissue response to radiation therapy is due to several
different factors (Turesson, 1989; Turesson and Thames, 1989;
Tucker et al, 1992). As the relationship between cellular sensitivity
and tissue response is imperfect, a method for studying the under-
lying mechanisms ofradiation-induced fibrosis, taking into account
different contributing factors, is warranted (Burnet et al, 1992,
1994; Geara et al, 1996; Turesson et al, 1996). Further, it should be
specific for one type of injury or even for one type of tissue
(Bentzen et al, 1993).
As type I collagen accounts for70-80% and type III collagen for
10-15% of the total collagen in skin (Bauer and Uitto, 1979), the
modulation oftheir synthesis by radiation therapy is clinically very
interesting and important. Collagen molecules are first synthesized
as procollagen molecules, each of them including additional
carboxy- and aminoterminal propeptides at the ends of the mole-
cules (Figure 1) (Risteli and Risteli, 1990). These propeptides are
cleaved off at the extracellular matrix in a 1:1 stoichiometric ratio
to mature collagen molecules assembling into collagen fibres
(Figure 1). The molecular shape of the aminoterminal propeptides
is elongated and rod-like, whereas the shape ofthe carboxyterminal
propeptides is globular (Figure 1). The molecular masses of type I
carboxy- and aminoterminal and type III aminoterminal propep-
tides are 100 000, 35 000 and 42 000 respectively.
Here, we used a sensitive, direct and non-invasive method,
based on the use of the suction blister technique (Kiistala, 1968)
and on the radioimmunoassays ofprocollagen propeptides (Risteli
et al, 1988; Melkko et al, 1990, 1996) to study local ongoing type
I and III collagen synthesis (Oikarinen et al, 1992) in the irradiated
and unirradiated skin of breast cancer patients 1-5 years after the
radiation therapy.
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Figure 1 Molecular structure of types and IlIl procollagen molecules, indicating the cleavage sites of the propeptides. (N-terminal, aminoterminal; C-terminal,
carboxyterminal). Reprinted with permission
Table 1 Patients and treatment characteristics
Patient Time from Age TNM Systemic Operation RT Energy Skin
no. RT to blister (years) treatment total/ reaction
induction daily dose (WHO)
(years) (Gy)
1 1 68 Tl Nl MO E M 50/2 e9 MeV 1
2 1 45 Tl NlMO CMF M 50/2 e6 MeV 1
3 1.5 53 Tl NOMO - M 50/2 e6 MeV 1
4 2 53 T2NOMO - M 50/2 e9MeV 1
5 3 67 TlNlMO E R 50+10/2a x6 MV 1
6 3 49 T2N1MO CMF M 50/2 e6 MeV 2
7 3 53 T2N1M1 CMF+Eb M 50/2 e6 MeV 1
8 3 46 T2N1MO E M 50/2 e6 MeV 1
9 3 47 T2N11MO CMF+E M 50/2 e6 MeV 2
10 3 45 T3N1M1 CMF+E M 46/2c e6 MeV 2
11 3 55 T1N2MO CMF M 50/2 e6 MeV 2
12 4 58 T2NOMO - M 50/2 e6 MeV 2
13 4 77 TlNlMO E M 50/2 e6 MeV 0
14 5 53 T1N1MO CMF M 50/2 e6 MeV 1
15 5 64 T2N1MO E M 50/2 e6 MeV 0
RT, radiotherapy; E, endocrine therapy; CMF, chemotherapy (cyclophosphamide, methotrexate, 5-fluorouracil); M, mastectomy; R, resection; e, electron; x,
photon; WHO 0, no reaction; WHO 1, erythema; WHO 2, dry desquamation. al0-Gy booster to the operation scar. b Skin metastases operated from the scar
1 year after the radiotherapy. cRadiotherapy discontinued because of skin reaction.
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Figure 2 Mean concentrations (+ 1 s.d.) of type and III procollagen
propeptides in suction blister fluid. PICP, carboxyterminal propeptide of type
procollagen; PINP, aminoterminal propeptide of type procollagen; PIIINP,
aminoterminal propeptide of type Ill procollagen
PATIENTS AND METHODS
Patients
Fifteen randomly chosen women who had been treated for breast
cancer 1-5 years earlier with radiation therapy were included in
the study (mean age 57 years, range 45-77 years) (Table 1). The
study was carried out in accordance with the provisions of the
declaration ofHelsinki.
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Methods
Five suction blisters, 6 mm in diameter, were simultaneously
induced on the irradiated skin and five blisters on the corre-
sponding skin area of the contralateral breast of each patient to
obtain suction blister fluid (SBF) (i.e. interstitial fluid). A negative
pressure of 200-400 mmHg in the suction blister device was used.
The total amount ofSBF obtained from five blisters was altogether
250-500 ,tl. SBF was immediately frozen at -700 after induction
until analysed. A blood sample was taken from the cubital vein;
the serum was separated and frozen.
Concentrations of carboxy- and aminoterminal propeptides of
type I procollagen (PICP and PINP respectively) and aminoter-
minal propeptide oftype III procollagen (PIIINP) were determined
from SBF obtained from both skin areas and serum using specific
radioimmunoassays against human antigens (Orion Diagnostica,
Oulunsalo, Finland) (Risteli et al, 1988; Melkko et al, 1990, 1996).
Radioimmunoassay for the carboxyterminal propeptide of type III
procollagen is currently not available.
The mean concentrations and interindividual variation (± I s.d.)
of the procollagen propeptides in SBF derived from irradiated and
unirradiated skin and serum were calculated. In addition, the rela-
tive ratio of PICP and PINP (PICP/PINP) was calculated (taking
into account the molecular masses ofthe propeptides) to determine
the possible effect of radiation therapy on the cleavage of the
propeptides from the type I procollagen molecule. The relative
ratio of PIIINP and PINP (PIIINP/PINP) was calculated (taking
into account the molecular masses of the propeptides) to study
whether radiation therapy alters the relative synthesis of types III
and I collagen in human skin.
The relative concentration ofPICP, PINP and PIIINP in SBF of
irradiated and unirradiated skin was estimated separately in
patients who had received radiation therapy approximately 1, 2, 3,
4 and 5 years earlier.
For comparisons, two-tailed, paired Student's t-test assuming
unequal distribution was used.
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Figure 3 Relative suction blister fluid concentrations (+ 1 s.d.) of types
and Ill procollagen propeptides in irradiated vs unirradiated skin with the
correlation of time after radiation therapy. SBF,, suction blister fluid from
irradiated skin; SBF2, suction blister fluid from unirradiated skin. (Patient no.
3 is included into the group defined as being 2 years from RT to blister
induction)
RESULTS
The mean (± 1 s.d.) concentrations of PICP were 450 ± 252 ,ug 1-'
and 229 ± 102 gg 1- in SBF obtained from irradiated and contra-
lateral skin respectively (Figure 2). The difference was significant
(P = 0.011). In addition, the mean (± 1 s.d.) concentration ofPINP
was significantly (P = 0.021) higher in SBF obtained from irradi-
ated skin (304 ± 225 jig 1-') than in SBF derived from contralateral
skin (152 ± 112 ,ug 1-') (Figure 2). The mean (± 1 s.d.) con-
centration of PIIINP in SBF obtained from irradiated skin was
109 ± 87 jig 1-1 and 49 ± 35 jig 1-1 in SBF derived from contralat-
eral skin (Fig. 2); this difference was also significant (P = 0.013).
In serum the mean PICP, PINP and PIIINP concentrations were
10 50, 43 ± 27 and 3.6 ± 0.9 jg 1-' respectively.
The relative ratios PICP/PINP were 0.37 ± 0.07 and 0.39 ± 0.1
in SBF obtained from the irradiated and the contralateral skin
respectively. The difference was not significant. The relative ratios
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PIIINP/PINP were 0.22 ± 0.05 and 0.22 ± 0.07 in the SBF
obtained from the irradiated and the contralateral skin respectively.
This difference was also not significant. The mean relative
concentrations of PICP in SBF from irradiated and unirradiated
skin and the corresponding mean relative concentrations for PINP
and PIIINP were highest 1-2 years after radiation therapy, there-
after slowly decreasing with time (Figure 3).
DISCUSSION
We simultaneously induced suction blisters on irradiated and unir-
radiated skin ofbreast cancer patients. The blister is created with a
negative pressure that raises epidermis and leaves the intact basal
membrane on the dermal surface. The vessels remain intact and
proteins flow into the blister compartment according to their mole-
cular size (Vermeer et al, 1979). The induction takes 1-2 h, does
not cause pain and the blister sites heal rapidly without scar forma-
tion (Kiistala, 1968).
As the procollagen propeptides are cleaved off in extracellular
matrix into the interstitial fluid when a collagen molecule is
formed (Risteli and Risteli, 1990), it is possible to measure the
actual collagen synthesis in skin by measuring the concentrations
of the propeptides in interstitial fluid (Oikarinen et al, 1992). The
concentrations of PICP and PINP, and PIIINP, respectively, have
been shown to indicate the local ongoing synthesis of type I and
type III collagen in dermis (Oikarinen et al, 1992; Autio et al,
1994, 1996). The synthesis of procollagens slowly decreases with
age, being most obvious after the seventh decade.
In the irradiated skin, the mean SBF concentrations of PICP,
PINP and PIIINP were about two times higher than in the contralat-
eral skin (Figure 2). This indicates that synthesis rates oftypes I and
III collagen are significantly increased until 1-2 years after therapy
(Figure 3). Thereafter, the synthesis slowly decreases in the irradi-
ated skin approaching the synthesis rate of the non-irradiated skin
(Figure 3). Several studies have indicated a non-linear time course
ofcollagen mRNA and cytokine levels post irradiation (Rubin et al,
1995; Randall and Coggle, 1996). In order to clarify the time course
of collagen synthesis with the present method, extensive measure-
ments with a large number of patients are needed. The concentra-
tions of PICP and PIIINP increase markedly in wound fluid after
surgery but normalize within a few months (Haukipuro et al, 1992).
Hence, the increased skin collagen synthesis can not be due to the
healing ofmastectomy wounds.
Several studies have indicated that the skin synthesis of type I
and III collagens is tightly co-regulated (Oikarinen et al, 1992;
Autio et al, 1994). In addition, the present results indicate that type
III collagen synthesis accounts for about 22% of the total skin
synthesis of type I and III collagens, irrespective of the radiation
therapy, which is consistent with previous estimates in physio-
logical conditions (Autio et al, 1994).
Our results further indicate that the cleavage of amino- and
carboxyterminal propeptides from type I procollagen molecule
remains intact despite radiation therapy, enabling normal binding
of collagen molecules into fibres and bundles. Previous results
obtained with patients under certain systemic treatments have also
indicated similar co-ordinated cleavage rates (Autio et al, 1994).
The serum concentrations of PICP and PINP mainly reflect the
turnover of bone type I collagen, whereas that of PIIINP reflects
the synthesis of type III collagen in soft tissues of the whole body
(Risteli and Risteli, 1990).
Mean serum concentrations of PICP, PINP and PIIINP were, in
our patients, inside the normal reference values, as expected, as
serum concentrations rarely reflect local changes in dermal
collagen metabolism (Autio et al, 1993).
This is the first in vivo demonstration of increased collagen
synthesis in human irradiated skin. Increased SBF concentrations
of PICP and PIIINP have been shown in fibrogenetic scleroderma
skin, in line with the present results (S0ndergaard et al, 1997). In
the near future, it will become possible to measure degradation
products of collagens in SBF and thus to elucidate the total
turnover of skin collagens. If, in a prospective setting, this method
is combined with biophysical techniques and the results achieved
with fibroblast cultures, it will be possible to get a more precise
insight into the mechanisms occurring under radiation-induced
fibrogenesis.
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